asthma bronchopulmonary hyperreactivity
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patient attending the pediatric outpatient department of the St. Lucas Andreas hospital or the Academic Medical Centre. - Patient has been treated with fluticason for at least 3 months using a pressurized metered-dose inhaler. - Maximum age: 11 years old. - Dutch, Moroccan, Turkish ethnicity.
Exclusion criteria
Exclusion criteria: - Patient refuses to participate in the study. - Patient is not capable of using the equipment for electronic measurement of compliance correctly#.;#These patient are requested to participate in the interview. In addition, patient characteristics are collected to investigate whether these patients differ from the ones that are capable of using the RTMEMS-equipment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Electronically measured compliance is the primary outcome measure; the influence of the determinants on compliance will be analysed. | — |
Secondary
| Measure | Time frame |
|---|---|
| As a secondary outcome measure the accuracy of the information on compliance from the questionnaire will be compared to the RTMEMS. | — |
Countries
Netherlands